Nuveen Asset Management, LLC Concert Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $1.05 Million - $1.45 Million	-277,611 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.86 - $13.07 $50,053 - $134,607	-10,299 Reduced 3.58%	277,611 $1.39 Million
Q4 2020 Feb 16, 2021	SELL	$9.48 - $12.84 $8,588 - $11,633	-906 Reduced 0.31%	287,910 $3.64 Million
Q3 2020 Nov 16, 2020	SELL	$8.67 - $10.82 $441,589 - $551,095	-50,933 Reduced 14.99%	288,816 $2.84 Million
Q2 2020 Aug 14, 2020	SELL	$7.8 - $11.52 $337,630 - $498,654	-43,286 Reduced 11.3%	339,749 $3.38 Million
Q1 2020 May 14, 2020	BUY	$5.98 - $13.09 $323,380 - $707,867	54,077 Added 16.44%	383,035 $3.39 Million
Q4 2019 Feb 14, 2020	SELL	$5.71 - $9.22 $659,002 - $1.06 Million	-115,412 Reduced 25.97%	328,958 $3.04 Million
Q3 2019 Nov 14, 2019	SELL	$5.88 - $12.35 $93,209 - $195,772	-15,852 Reduced 3.44%	444,370 $2.61 Million
Q2 2019 Aug 15, 2019	BUY	$9.44 - $13.12 $4.34 Million - $6.04 Million	460,222 New	460,222 $5.52 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.